Search research articles
Contact Us
Filters
Showing results (81-90 of 93) with videos related to
Page
of 10
Sort By:
Journal of Cardiovascular Electrophysiology
|
June 20, 2020
Recurrent ventricular tachycardia after cardiac sympathetic denervation: Prolonged cycle length with improved hemodynamic tolerance and ablation outcomes
Justin Hayase, Veronica Dusi, Duc Do, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 6, 2009
Snail promotes CXCR2 ligand-dependent tumor progression in non-small cell lung carcinoma
Jane Yanagawa, Tonya C Walser, Li X Zhu, et al.
American Journal of Translational Research
|
August 27, 2013
Elevated neutrophil gelatinase-associated lipocalin contributes to erlotinib resistance in non-small cell lung cancer
Kostyantyn Krysan, Xiaoyan Cui, Brian K Gardner, et al.
Cancer Research
|
May 31, 2019
The Immune Contexture Associates with the Genomic Landscape in Lung Adenomatous Premalignancy
Kostyantyn Krysan, Linh M Tran, Brandon S Grimes, et al.
Cancer Research Communications
|
March 21, 2025
The Impact of the Tumor Microenvironment on the Effect of IL-1β Blockade in NSCLC: Biomarker Analyses from CANOPY-1 and CANOPY-N Trials
Benjamin J Solomon, Daniel S W Tan, Gilberto de Castro, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 6, 2023
Safety and Efficacy Results From iSABR, a Phase 1 Study of Stereotactic ABlative Radiotherapy in Combination With Durvalumab for Early-Stage Medically Inoperable Non-Small Cell Lung Cancer
Trudy C Wu, Annalise Stube, Carol Felix, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 5, 2017
Phase I Trial of Intratumoral Injection of <i>CCL21</i> Gene-Modified Dendritic Cells in Lung Cancer Elicits Tumor-Specific Immune Responses and CD8<sup>+</sup> T-cell Infiltration
Jay M Lee, Mi-Heon Lee, Edward Garon, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 9, 2023
Artificial Intelligence-Powered Assessment of Pathologic Response to Neoadjuvant Atezolizumab in Patients With NSCLC: Results From the LCMC3 Study
Sanja Dacic, William D Travis, Jennifer M Giltnane, et al.
Nature Medicine
|
October 10, 2023
Author Correction: Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial
Jamie E Chaft, Filiz Oezkan, Mark G Kris, et al.
Nature Medicine
|
September 13, 2022
Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial
Jamie E Chaft, Filiz Oezkan, Mark G Kris, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 93) with videos related to
Sort By:
Page
of 10
Journal of Cardiovascular Electrophysiology
|
June 20, 2020
Recurrent ventricular tachycardia after cardiac sympathetic denervation: Prolonged cycle length with improved hemodynamic tolerance and ablation outcomes
Justin Hayase, Veronica Dusi, Duc Do, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 6, 2009
Snail promotes CXCR2 ligand-dependent tumor progression in non-small cell lung carcinoma
Jane Yanagawa, Tonya C Walser, Li X Zhu, et al.
American Journal of Translational Research
|
August 27, 2013
Elevated neutrophil gelatinase-associated lipocalin contributes to erlotinib resistance in non-small cell lung cancer
Kostyantyn Krysan, Xiaoyan Cui, Brian K Gardner, et al.
Cancer Research
|
May 31, 2019
The Immune Contexture Associates with the Genomic Landscape in Lung Adenomatous Premalignancy
Kostyantyn Krysan, Linh M Tran, Brandon S Grimes, et al.
Cancer Research Communications
|
March 21, 2025
The Impact of the Tumor Microenvironment on the Effect of IL-1β Blockade in NSCLC: Biomarker Analyses from CANOPY-1 and CANOPY-N Trials
Benjamin J Solomon, Daniel S W Tan, Gilberto de Castro, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 6, 2023
Safety and Efficacy Results From iSABR, a Phase 1 Study of Stereotactic ABlative Radiotherapy in Combination With Durvalumab for Early-Stage Medically Inoperable Non-Small Cell Lung Cancer
Trudy C Wu, Annalise Stube, Carol Felix, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 5, 2017
Phase I Trial of Intratumoral Injection of <i>CCL21</i> Gene-Modified Dendritic Cells in Lung Cancer Elicits Tumor-Specific Immune Responses and CD8<sup>+</sup> T-cell Infiltration
Jay M Lee, Mi-Heon Lee, Edward Garon, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 9, 2023
Artificial Intelligence-Powered Assessment of Pathologic Response to Neoadjuvant Atezolizumab in Patients With NSCLC: Results From the LCMC3 Study
Sanja Dacic, William D Travis, Jennifer M Giltnane, et al.
Nature Medicine
|
October 10, 2023
Author Correction: Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial
Jamie E Chaft, Filiz Oezkan, Mark G Kris, et al.
Nature Medicine
|
September 13, 2022
Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial
Jamie E Chaft, Filiz Oezkan, Mark G Kris, et al.
Page
of 10